RBC Capital Maintains Outperform on Verastem, Raises Price Target to $19
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and raises the price target from $14 to $19.
RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and raises the price target from $14 to $19.